Intelligent Bio Solutions Inc (INBS)
1.64
+0.24
(+17.14%)
USD |
NASDAQ |
Nov 21, 16:00
1.69
+0.05
(+3.05%)
After-Hours: 07:16
Intelligent Bio Solutions Enterprise Value: 3.549M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 3.549M |
| November 20, 2024 | 2.496M |
| November 19, 2024 | 2.409M |
| November 18, 2024 | 2.540M |
| November 15, 2024 | 2.847M |
| November 14, 2024 | 3.023M |
| November 13, 2024 | 3.812M |
| November 12, 2024 | 4.865M |
| November 11, 2024 | 4.427M |
| November 08, 2024 | 3.505M |
| November 07, 2024 | 3.900M |
| November 06, 2024 | 3.023M |
| November 05, 2024 | 3.154M |
| November 04, 2024 | 2.540M |
| November 01, 2024 | 2.440M |
| October 31, 2024 | 2.308M |
| October 30, 2024 | 2.834M |
| October 29, 2024 | 3.009M |
| October 28, 2024 | 3.315M |
| October 25, 2024 | 3.184M |
| October 24, 2024 | 2.659M |
| October 23, 2024 | 2.746M |
| October 22, 2024 | 3.053M |
| October 21, 2024 | 2.921M |
| October 18, 2024 | 3.228M |
| Date | Value |
|---|---|
| October 17, 2024 | 2.790M |
| October 16, 2024 | 2.878M |
| October 15, 2024 | 2.746M |
| October 14, 2024 | 2.702M |
| October 11, 2024 | 2.878M |
| October 10, 2024 | 2.790M |
| October 09, 2024 | 3.053M |
| October 08, 2024 | 2.834M |
| October 07, 2024 | 3.447M |
| October 04, 2024 | 3.315M |
| October 03, 2024 | 3.753M |
| October 02, 2024 | 3.184M |
| October 01, 2024 | 3.578M |
| September 30, 2024 | 3.928M |
| September 27, 2024 | 1.800M |
| September 26, 2024 | 1.927M |
| September 25, 2024 | 2.182M |
| September 24, 2024 | 1.587M |
| September 23, 2024 | 1.374M |
| September 20, 2024 | 2.054M |
| September 19, 2024 | 1.693M |
| September 18, 2024 | 3.372M |
| September 17, 2024 | 4.604M |
| September 16, 2024 | 3.584M |
| September 13, 2024 | 0.9768M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-4.850M
Minimum
Feb 22 2022
149.04M
Maximum
Dec 23 2020
11.63M
Average
3.281M
Median
Enterprise Value Benchmarks
| Standard BioTools Inc | 291.94M |
| Ainos Inc | 13.27M |
| Zomedica Corp | 51.69M |
| LENSAR Inc | 68.45M |
| Adagio Medical Holdings Inc | 20.24M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.686M |
| Revenue (Quarterly) | 0.8723M |
| Total Expenses (Quarterly) | 3.598M |
| EPS Diluted (Quarterly) | -8.40 |
| Gross Profit Margin (Quarterly) | 39.76% |
| Profit Margin (Quarterly) | -307.9% |
| Earnings Yield | -2.16K% |
| Normalized Earnings Yield | -2196.97 |